Protection by vaccines and previous infection against the omicron variant of severe acute respiratory syndrome coronavirus 2
Background The Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
evades immunity conferred by vaccines and previous infections. Methods We used …
evades immunity conferred by vaccines and previous infections. Methods We used …
Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia
Studies demonstrating the waning of post-vaccination and post-infection immunity against
covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using …
covid-19 generally analyzed a limited range of vaccines or subsets of populations. Using …
Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations
Background: Short-term forecasts of infectious disease burden can contribute to situational
awareness and aid capacity planning. Based on best practice in other fields and recent …
awareness and aid capacity planning. Based on best practice in other fields and recent …
Real-life protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in the Czech Republic …
Background Evidence is accumulating that the effectiveness of covid-19 vaccines against
infection wanes, reaching relatively low values after 6 months. Published studies …
infection wanes, reaching relatively low values after 6 months. Published studies …
[HTML][HTML] On the contact tracing for COVID-19: a simulation study
Background: Contact tracing is one of the most effective non-pharmaceutical interventions
in the COVID-19 pandemic. This study uses a multi-agent model to investigate the impact of …
in the COVID-19 pandemic. This study uses a multi-agent model to investigate the impact of …
Use of COVID-19 convalescent plasma in low-and middle-income countries: a call for ethical principles and the assurance of quality and safety
J Epstein, M Smid, S Wendel, D Somuah, T Burnouf - Vox sanguinis, 2021 - research.rug.nl
Most high-income countries are aggressively engaged in the collection and research evaluation
of convalescent plasma as a specific passive immunotherapy for treatment of COVID-19…
of convalescent plasma as a specific passive immunotherapy for treatment of COVID-19…
Protection by vaccines and previous infection against the Omicron variant of SARS-CoV-2
… Martin Smid; Ludek Berec; Ondrej Majek; Tomas Pavlik; Jiri Jarkovsky; Lenka Pribylova;
Jakub Weiner; Tamara Barusova; Jan Trnka. … Martin Smid; Czech Academy of Sciences …
Jakub Weiner; Tamara Barusova; Jan Trnka. … Martin Smid; Czech Academy of Sciences …
Delays, masks, the elderly, and schools: First covid-19 wave in the czech republic
Running across the globe for nearly 2 years, the Covid-19 pandemic keeps demonstrating
its strength. Despite a lot of understanding, uncertainty regarding the efficiency of …
its strength. Despite a lot of understanding, uncertainty regarding the efficiency of …
Multi-stage emissions management of a steel company
We present a multi-stage model for determining the optimal production and emissions coverage
for an industrial company participating in the European Emissions Trading System. This …
for an industrial company participating in the European Emissions Trading System. This …
Stepwise access to safe plasma proteins in resource‐constrained countries: Local production and pathways to fractionation—Report of an International Society of …
T Burnouf, J Epstein, JC Faber, M Smid - Vox Sanguinis, 2022 - Wiley Online Library
Background and Objectives Actions are needed to improve access to safe plasma‐derived
medicinal products (PDMPs) in low‐ and middle‐income countries (LMICs). Materials and …
medicinal products (PDMPs) in low‐ and middle‐income countries (LMICs). Materials and …